http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2017, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 28 Oct 2016 02:46:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html Fri, 28 Oct 2016 02:46:00 -0400 4589 A.29684066 http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Listing+Approval+of+Kubota+Pharmaceutical+Holdings/12178343.html Fri, 28 Oct 2016 02:46:00 -0400 4589 A.29684066 http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html Tue, 18 Oct 2016 19:06:00 -0400 4589 A.03309922 http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Issues+Notice+of+Resolutions+of+the+Annual+Meeting+of+Shareholders/12144372.html Tue, 18 Oct 2016 19:06:00 -0400 4589 A.03309922 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Official+Name+of+Acucela+Japan+as+Kubota+Pharmaceutical+Holdings+Co.%2C+Ltd./11922000.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Official+Name+of+Acucela+Japan+as+Kubota+Pharmaceutical+Holdings+Co.%2C+Ltd./11922000.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Official+Name+of+Acucela+Japan+as+Kubota+Pharmaceutical+Holdings+Co.%2C+Ltd./11922000.html Tue, 09 Aug 2016 19:10:00 -0400 4589 http://www.streetinsider.com/Press+Releases/Announcement+Regarding+the+News+Coverage+Concerning+an+Inquiry+on+Trades+of+Acucela+Shares/11761940.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Announcement+Regarding+the+News+Coverage+Concerning+an+Inquiry+on+Trades+of+Acucela+Shares/11761940.html for the full story. http://www.streetinsider.com/Press+Releases/Announcement+Regarding+the+News+Coverage+Concerning+an+Inquiry+on+Trades+of+Acucela+Shares/11761940.html Tue, 21 Jun 2016 20:28:00 -0400 4589 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html Mon, 13 Jun 2016 18:41:00 -0400 4589 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Termination+of+Emixustat+Agreement+and+OPA-6566+Agreement+with+Otsuka+Pharmaceutical%2C+and+Postponement+of+Annual+Shareholder+Meeting/11736154.html Mon, 13 Jun 2016 18:41:00 -0400 4589 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Wed, 25 May 2016 18:47:00 -0400 4589 A.13296698 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Wed, 25 May 2016 18:47:00 -0400 4589 A.13296698 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+Top-Line+Results+from+Phase+2b3+Clinical+Trial+of+Emixustat/11675805.html Wed, 25 May 2016 18:47:00 -0400 4589 A.13296698 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Sun, 08 May 2016 19:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Sun, 08 May 2016 19:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Initiates+Phase+2+Clinical+Trial+Addressing+Proliferative+Diabetic+Retinopathy/11601136.html Sun, 08 May 2016 19:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Thu, 21 Apr 2016 19:36:00 -0400 4589 A.02042075 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Thu, 21 Apr 2016 19:36:00 -0400 4589 A.02042075 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+to+Present+at+ARVO+2016+Annual+Meeting%E2%80%99s+Education+Courses+in+Seattle/11530152.html Thu, 21 Apr 2016 19:36:00 -0400 4589 A.02042075 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Tue, 19 Apr 2016 02:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Tue, 19 Apr 2016 02:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Announces+End+of+Treatment+Period+in+Phase+2b3+Clinical+Trial+of+Emixustat+Hydrochloride/11515398.html Tue, 19 Apr 2016 02:36:00 -0400 4589 A.06822034 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Mon, 04 Apr 2016 19:40:00 -0400 4589 A.06762253 A.28281860 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Mon, 04 Apr 2016 19:40:00 -0400 4589 A.06762253 A.28281860 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Mon, 04 Apr 2016 19:40:00 -0400 4589 A.06762253 A.28281860 A.29331106 http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html for the full story. http://www.streetinsider.com/Press+Releases/Acucela+Licenses+Gene+Therapy+from+The+University+of+Manchester+for+Retinal+Degenerative+Disease/11473611.html Mon, 04 Apr 2016 19:40:00 -0400 4589 A.06762253 A.28281860 A.29331106